Listen "2025 Retina Update, Part 1: Injectables in the Medical Retina Space"
Episode Synopsis
Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related macular degeneration (AMD) therapies, private equity acquisitions, and the new drug pipeline. For all episodes or to claim CME credit for selected episodes, visit www.aao.org/podcasts.
More episodes of the podcast Experts InSight
CMS Cuts Rock Ophthalmology and Medicine
21/08/2025
A Journey Through Vision Loss
08/08/2025
Updates on Optic Disc Drusen
25/07/2025
Intraocular Pressure Variance
27/06/2025
Updates in Amblyopia Treatment
12/06/2025